FMP
Willow Biosciences Inc.
WLLW.TO
TSX
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
0.09 CAD
-0.005 (-5.56%)
About
ceo
Dr. Chris Savile
sector
Healthcare
industry
Drug Manufacturers - Specialty & Generic
website
https://www.willowbio.com
exchange
TSX
Description
Willow Biosciences Inc., a biotechnology company, develops, produces, and sells plant derived ingredients for consumer care, food and beverage, and pharmaceutical product industries in Canada. The company also produces cannabidiol, cannabigerol, and varin cannabinoids, such as cannabigerovarin, cannabidivarin, and tetrahydrocannabivarin. Willow Biosciences Inc. was incorporated in 1981 and is headquartered in Calgary, Canada.
CIK
N/A
ISIN
CA97111B4047
CUSIP
97111B404
Address
202, 1201-5th Street SW
Phone
403 910 5140
Country
CA
Employee
19
IPO Date
Feb 11, 2021
Key Executives
